Quantcast

Latest Nebulizer Stories

2008-10-03 09:00:07

Transave, a biopharmaceutical company, has secured a $12.5 million venture loan from CIT Healthcare and Compass Horizon Funding Company, an affiliate of Horizon Technology Finance Management. Transave has previously reported positive Phase II data on Arikace from a randomized, placebo-controlled, 15-center study conducted in Europe. The study demonstrated that Arikace, delivered once daily for 28 consecutive days using a novel inhalation device, an investigational eFlow nebulizer system...

2008-10-02 12:03:43

MONMOUTH JUNCTION, N.J., Oct. 2 /PRNewswire/ -- Transave, Inc., a biopharmaceutical company focused on developing innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases, today announced that it has secured a $12.5 million venture loan from CIT Healthcare and Compass Horizon Funding Company LLC, an affiliate of Horizon Technology Finance Management LLC. In June, Transave, Inc. reported positive Phase II data on Arikace(TM) (liposomal amikacin for...

2008-10-01 06:00:29

Research and Markets (http://www.researchandmarkets.com/research/45fffb/delivering_drugs_b) has announced the addition of the "Delivering Drugs by Inhalation - Emerging Therapeutic Opportunities" report to their offering. Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic...

2008-09-30 15:00:17

Teleflex Medical, a leading global supplier of disposable products for critical care and surgical applications, has received clearance from the FDA to market the Hudson RCI Neb-U-Mask(R), a respiratory device that allows for the concurrent delivery of aerosolized medication and a high concentration of medical gases to treat acute asthma exacerbations. Asthma is a chronic inflammatory disease of the airways. According to the National Asthma Education and Prevention Program, asthma affects...

2008-09-05 12:00:09

MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturday, September 6, PARI Respiratory Equipment will be featured on the Oxygen Network show Today's Family as part of their "Breathe Easier" series. PARI is highlighted as a leading medical device company that provides patients, such as COPD sufferers, with effective nebulizers and compressors that deliver needed medications directly to the lungs. "Our vision is to improve the lives of those affected by respiratory diseases and those who care...

2008-08-22 09:01:11

Kamada has completed a Phase II study with aerosolized alpha-1 antitrypsin, delivered via an optimized eFlow platform nebulizer from PARI Pharma, in cystic fibrosis. The trial aimed at validating the safety of the product in cystic fibrosis patients and to assess its potential influence on lung inflammation. Preliminary results indicate that the product has an excellent safety profile; final data should be available by year-end 2008, said Kamada. The trial, which was a double-blind,...

2008-08-21 09:01:14

Kamada (TASE: KMDA), a bio-pharmaceutical company (www.kamada.com) engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has completed a Phase II Study with Aerosolized Alpha-1 Antitrypsin (AAT), delivered via an optimized eFlow platform nebulizer (PARI Pharma GmbH), in cystic fibrosis (CF). Preliminary results indicate that the product has an excellent safety profile; final data should be available by year-end 2008. David...

2008-07-20 12:00:16

By Annie Getsinger, Herald & Review, Decatur, Ill. Jul. 20--DECATUR -- Intent on gaining a better understanding of asthma management, participants at the Techniques and Tools of the Trade workshop visited stations where experts instructed them on medication devices and assessment tools such as metered dose inhalers, nebulizer treatments, dry powder medications and peak flow meters. More than 40 health care providers from the central region of the Illinois Asthma Partnership gathered...

2008-06-30 09:02:20

SILVER SPRING, Md., June 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation and its wholly-owned subsidiary, Lung Rx, Inc., announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of an inhaled formulation of treprostinil (ITRE) for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disease. The submission starts a 60-day period during which the FDA will examine the...

62faf5e5713ad4acb8875fa8971995831
2008-05-28 10:30:00

The nightmare seems to continue for the victims of Hurricane Katrina like Gina Bouffanie and her daughter. Since leaving their FEMA trailer Bouffanie's daughter has suffered severe breathing problems."It's just the sickness. I can't get rid of it. It just keeps coming back," said Bouffanie, 27, who was pregnant with her now 15-month-old daughter, Lexi, while living in the trailer. " If I had known it would get her sick, I wouldn't have stayed in the trailer for so long."Her daughter was...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.